Full Press Release Details
INDIANAPOLIS , Dec. 5, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) has released its 2012-13 Corporate Responsibility Report . The report offers a comprehensive look at the company's progress on numerous corporate responsibility goals and efforts, including:
"Lilly's greatest contribution to society is continuing to discover and develop innovative medicines that help make life better," said John C. Lechleiter , Ph.D., Lilly chairman, president, and chief executive officer. "Being a trustworthy global citizen also requires us to conduct our business ethically, responsibly, and transparently—and to strategically use our resources, knowledge, and capabilities to help improve global health and bring value to patients, society, and shareholders."
Among the report's highlights:
The Lilly 2012-13 Corporate Responsibility Report also serves as Lilly's annual Communication on Progress to the United Nations Global Compact (UNGC). As a signatory of the UNGC, Lilly shares its progress annually on 10 universally accepted principles related to human rights, labor, the environment, and anti-corruption.
This year's report is available on Lilly.com .
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind. , Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com . CR-LLY
Refer to: (317) 489-7109 - David Marbaugh
SOURCE Eli Lilly and Company